Sentiment Trading

Adagene Inc. navigates market challenges with a strategic focus on cancer treatment, leveraging its dual presence in the US and China to drive growth and innovation in the biotechnology sector.

Adagene Inc.’s financial struggles and volatile stock performance raise questions about its future in the competitive biotech sector, despite its commitment to developing innovative cancer treatments.